Avanti Polar Lipids (Croda Pharma)
Is this your company? Claim this profile
Advanced Modalities
Excipients & Specialty Ingredients
Company Overview
About
Avanti Polar Lipids (Croda Pharma) is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Biologics Manufacturing, Monoclonal Antibodies, Vaccines
Therapeutic Areas
Oncology
Hematology
Quick Facts
HQ:United States
Founded:2018
Employees:1,907
Capabilities & Services
Core Capabilities
- Oral Solid Dose
- Solid Dose Manufacturing
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Lyophilized (Freeze-Dried)
Sterile Injectable
Containment Capabilities
Cytotoxic / ADC Handling
Production Scales
R&D / Pre-clinical
Lab Scale
Pilot Scale
Markets Served
North America
Manufacturing Facilities
1 site worldwide
Avanti Polar Lipids
700 Industrial Park Drive, Alabaster, Alabama, 35007
Site Capabilities
1 capabilityAPI MANUFACTURE
Regulatory Approvals
Drug Approval 6DGP2T
PMDA · #APR-ZHCE0ZMJ · 2018-11-01
Certifications
ISO 9001:2015
International Organization for Standardization
Cert #: CERT-4RB8KWS1
Issued: 2020-09-02
Expires: 2025-04-22
ISO 13485:2016
International Organization for Standardization
Cert #: CERT-0JQ3X59A
Issued: 2020-06-20
Expires: 2025-02-28
Loading CDMO intelligence...
Key facts about Avanti Polar Lipids (Croda Pharma)
- Avanti Polar Lipids (Croda Pharma) is headquartered in the United States.
- Avanti Polar Lipids (Croda Pharma) was founded in 2018.
- Avanti Polar Lipids (Croda Pharma) has 1,907 employees.
- Avanti Polar Lipids (Croda Pharma) has one manufacturing site listed on CDMO Hub, in Alabaster, United States.
- Avanti Polar Lipids (Croda Pharma)'s capabilities include Oral Solid Dose, Solid Dose Manufacturing and Formulation Development.
Find CDMOs like Avanti Polar Lipids (Croda Pharma)
Directory pages this company appears in, each with the full list of matching manufacturers.